AlphaYouRC
Insider selling
Ryan Cohlhepp sold $401K of Bicara Therapeutics Inc. (BCAX) stock
Ryan Cohlhepp, President, COO & Interim CEO of Bicara Therapeutics Inc. (BCAX), sold 17,500 shares of BCAX stock worth $401K, per an SEC Form 4 filed Sep 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 8, 2026, 2 days before it was made public.
BCAX has moved -13.6% since the trade date, from $23.71 to $20.48 (Sep 23, 2026 close).
- Traded
- Sep 8, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 2 days
- Price since
- -13.6%
- Role
- President, COO & Interim CEO
- Source
- SEC Form 4
More BCAX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.